期刊文献+

恶性淋巴瘤患者凝血四项指标变化及意义 被引量:3

The Alteration of Coagulation Function in Patients with Malignant Lymphoma
下载PDF
导出
摘要 目的观察恶性淋巴瘤(ML)患者的凝血四项指标变化。方法应用磁珠法检测66例ML患者和20例健康体检者的凝血酶原时间(PT)、部分凝血活酶时间(APTT)、凝血酶时间(TT)和纤维蛋白原(FIB)水平。结果ML患者APTT、FIB水平显著高于对照组(P<0.05、P<0.01);Ⅲ期ML患者FIB水平高于对照组和Ⅱ期患者(P<0.05);Ⅳ期患者APTT、FIB水平均明显高于对照组和Ⅱ期患者(P<0.05、P<0.01)。结论ML患者常伴凝血指标异常,表现为高凝状态。 Objective To observe the alteration of blood coagulation indicators in the patients with malignant lymphoma(ML). Methods 66 patients with ML and 20 healthy subjects were recruited, and the levels of prothrombin time ( PT ), activated partial thromboplastin time ( APTT ), thrombin time (TT) and fibrinogen(FIB) in blood plasma were tested by magnetic bead method. Results The levels of APTT and FIB in ML patients were significant higher than those in controls( P 〈0.05 and 〈0.01 respectively). The FIB level in stage Ⅲ patients was higher than those in controls and stage Ⅱ patients( P 〈 0.05 ), and the levels of APTT and FIB in stage Ⅳ patients were significant higher than those in controls and stage Ⅱ patients( P 〈 0.05and 〈 0.01 respectively). Conclusion The ML patients usually accompany with abnormal coagulation function and hypereoagnlabale state.
出处 《医学综述》 2009年第23期3675-3676,共2页 Medical Recapitulate
关键词 恶性淋巴瘤 凝血指标 高凝状态 Malignant lymphoma Coagulation indicators Hypercoagnlabale state
  • 相关文献

参考文献8

  • 1Svendsen E ,Karwinski B. Prevalence of pulmonary embolism at necropsy in patients with cancer[J]. J Clin Pathol,1989,42(2):805-809.
  • 2Sase T, Wada H, Yamaguchi M, et al. Haemostatic abnormalities and thrombotic disorders in malignant lymphoma[ J ]. Thromb Haemost, 2005,93( 1 ) :153-159.
  • 3高文,陈文明,陈世伦.以深静脉血栓为首发表现的非霍奇金淋巴瘤二例并文献复习[J].白血病.淋巴瘤,2006,15(6):428-429. 被引量:2
  • 4Mousa SA. Anticoagulants in thrombosis and cancer: the missing link [ J ]. Expert Rev Anticancer Ther,2002,2 ( 2 ) :227-233.
  • 5黄松音,段朝晖,梁穆兴,林向华,范侠.肿瘤患者凝血指标变化的临床意义[J].血栓与止血学,2002,8(4):156-156. 被引量:33
  • 6Cloonan ME, DiNapoli M, Mousa sA. Efficacy of anticoagulants and platelet inhibitors in cancer-induced thrombosis [J]. Blood Coagul Fibrinolysis,2007,18 (4) :341-345.
  • 7Mousa SA. Low-molecular-weight heparin in thrombosis and cancer [ J]. Semin Thromb Hemost,2004,30( Suppl 1 ) :25-30.
  • 8Amirkhosravi A, Mousa SA, Amaya M, et al. Antimetastatic effect of tinzaparin, a low-molecular-weight heparin [ J ]. J Thromb Haemost, 2003,1 (9) : 1972-1976.

二级参考文献9

  • 1Deitcher R.Cancer and thrombosis:mechanism and treatment[J].Thrombosis Thrombolysis,2003,16(1/2):21-31.
  • 2Cushman M,Tsai A,White R,et al.Deep vein thrombosis and pulmonary embolism in two cohorts:the longitudinal investigation of thromboembolism etiology[J]:Am J Med,2004,117(1):19-25.
  • 3Goldschmidt N,Linetsky E,Shalom E,et al.High incidence of thromboembolism in patients with central nervous system lymphoma[J].Cancer,2003,98(6):1239-1242.
  • 4Mohren M,Markmann I,Jentsch-Ullrich K,et al.Increased risk of thromboembolism in patients with malignant lymphoma:a single-centre analysis[J].B J Cancer,2005,92(8):1349-1351.
  • 5Otten H,Mathijssen J,Cate H,et al.Symptomatic venous thromboembolism in cancer patients treated with chemotherapy:an underestimated phenomenon[J].Arch Intern Med,2004,164(2):190-194.
  • 6Nand S,Fisher S,Salgia R,et al.Hemostatic abnormalities in untreated cancer:incidence and correlation with thrombotic and hemorrhagic complications[J].J Clin Oncol,1987,5(12):1998-2003.
  • 7Zurborn K H,Pheiffer K F,Bruhn H D.Effect of therapy with cytostatic drugs on the hemostasis system in patients with small cell and non-small cell bronchial cancers,malignant lymphomas and plasmacytomas[J].Onkologie,1986,9(6):315-318.
  • 8王学锋,赵维莅,璩斌,程英,屠越峰,黄霞萍,王鸿利.肿瘤患者凝血及纤溶分子标志物变化[J].中华检验医学杂志,2000,23(6):331-333. 被引量:46
  • 9周立红,刘敏涓,董临江.血浆纤维蛋白原水平与功能测定对肝肾疾病、癌症及糖尿病的临床意义[J].血栓与止血学,2001,7(4):163-165. 被引量:3

共引文献33

同被引文献17

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部